Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

RLMD US Equity

Relmada Therapeutics, Inc.Health Care · Pharmaceutical Preparations · CIK 1553643 · FY ends Dec 31
$4.83
-0.02 (-0.41%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Squadron Capital Management LLCsec.gov ↗
2026-08-068-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2913GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-288-K 7.01Regulation FD disclosuresec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-28

Every row is a filed document, checked against its EDGAR index.